等待开盘 09-20 09:30:00 美东时间
+0.130
+1.09%
Oncolytics Biotech (TSE:ONC) has released an update. Oncolytics Biotech has ann...
09-19 19:27
Confirmed overall response rate (ORR) was 37.5% for pelareorep + paclitaxel and 13.3% for paclitaxel. As previously reported, ORRs at week 16 (the trial's primary endpoint) in the pelareorep
09-19 19:19
ACELYRIN, Inc. Announces Positive Results From Global Phase 3 Clinical Trial of...
09-19 19:00
ACELYRIN Inc : Morgan Stanley Cuts Target Price to $6 From $13
08-20 17:53
ACELYRIN Inc Shares Down 8.8% Premarket After H.c. Wainwright Cuts to Neutral
08-14 20:42
ACELYRIN Inc : Piper Sandler Cuts Target Price to $20 From $68
08-14 12:13
ACELYRIN-Approved Plan to Suspend New Internal Investment in Development of Izo...
08-14 04:18
ACELYRIN - Sees It Will Incur About $4.5 Mln in Cash-Based Expenses Related to ...
08-14 04:17
ACELYRIN Inc - as Part of Restructuring Plan, Workforce Will Be Reduced by Abou...
08-14 04:16
成分股诺瓦瓦克斯医药收跌25.70%表现最差,ACELYRIN跌10.40%,Anavex Life Sciences跌10.37%,Structure Th...
07-31 04:53